Researchers sought to determine whether ZA plus a proteasome inhibitor would reduce the risk of SREs in patients with MM.

A secondary analysis of cross-sectional studies identified 3 symptom clusters commonly experienced by breast cancer survivors with and without lymphedema.

Researchers investigated characteristics of adolescent and young adult patients with HCC and risk factors that affect survival.

Melanoma incidence decreased for those aged 20 to 29, 30 to 39, 40 to 49 years; decline in melanoma mortality seen for those aged 30 to 59 years.

(HealthDay News) — A postoperative wearable device may improve physical activity and patient-reported dyspnea at six months after lung cancer surgery, according to a study published online Sept. 20 in ...